Clinical trial
Prospective Survey of Menstrual Migraine & Prevention With Eletriptan
NCT00259649 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00259649 |
|---|---|
| Title | Prospective Survey of Menstrual Migraine & Prevention With Eletriptan |
| Official title | Assessment and Prevention of Menstrual Migraine: Phase 1-prospective Survey of Self-identified Menstrual Migraine. Phase 2-prevention of Menstrual Migraine With Relpax |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Drug |
| Interventions | eletriptan |
| Enrollment | 71 |
| Start date | Aug 1, 2004 |
| Primary completion | Aug 1, 2008 |
| First posted | Nov 29, 2005 |
| Last update posted | Jul 4, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: